Research, Clinical Trials & Audit
The Nottingham Breast Institute has its own small research team as well as working closely with the Nottingham Cancer Clinical Trials Team (NCCTT) and wider Clinical Research Network.
The in-house team run national and local audits as well as clinical trials and research projects. The team consists of a research co-ordinator, two research assistants, research data administrator and research fellow working closely alongside the nurse specialists, surgeons and wider breast services team.
Current Projects Include:
Surgery outcome– Women who are a year post reconstruction surgery are asked if at one of their appointments they would be happy to complete a questionnaire and possibly have some unidentifiable photos taken. The information and data gathered is used to help surgeons and patients make informed decisions on the appropriate surgery and likely outcome as presented at conferences worldwide.
iBRA – A national audit. No longer including new patients but data is still being collected from patients who have been registered. For more information click here.
iBRA 2– A national audit, click here for more information.
Electrochemotherapy – Evaluation of electrochemotherapy treatment. For more information on this click here.
SMBRA(SurgicalMeshBreastReconstructionAudit)– A local evaluation audit of meshes used in implant based breast reconstruction.
TeaM– A national audit, looking at a certain type of surgery called a Therapeutic Mammaplasty. Nottingham is one of the three centres in the UK taking part in the pilot for this audit. Click here for more information.
Engage Study: Decision –making in breast cancer prevention. Click here for more information
imILT Study: Interstitial laser thermotherapy as a treatment option in breast cancer patients not suitable for surgical excision. Click here for more information.
Perforator Study:Bra-line perforators of clinical value in breast reconstructive surgery; an anatomical study using quantitative Doppler. Click here to see the study flyer.
Loris Study: A Phase III Trial of Surgery vs Active Monitoring for Low Risk Ductal carcinoma in Situ (DCIS). Click here for more information.
SMART Study: Sentimag along with routine evaluation of sentinel node biopsy. Click here for more information. Due to open August / September 2016.
Contact and links
Breast Institute Research office:Malin, Lisa, Charlene and Kym 0115 9691169 ext 59057 / 55039
For information on other Breast / Oncology trials: Contact the NCCTT (Nottingham Cancer Clinical Trials Team)
For more information on research at this hospital click here
National information on research projects and clinical trials, click here